ZOLL LifeVest Prescribed by Physicians at All U.S. News and World Report "Honor Roll" Hospitals and All 50 "Best Cardiology and Heart Surgery" Hospitals
The Wall Street Journal
CHELMSFORD, Mass., Aug 29, 2011 (BUSINESS WIRE) -- ZOLL Medical Corporation /quotes/zigman/80334/quotes/nls/zoll ZOLL +2.87% , a manufacturer of medical devices and related software solutions, today announced that physicians at all of the 17 "Honor Roll" hospitals and all of the 50 "Best Cardiology and Heart Surgery" hospitals designated by U.S. News and World Report for 2011-2012 have prescribed the ZOLL LifeVest(R)Wearable Defibrillator for patients.
The LifeVest is worn by patients at risk for sudden cardiac arrest (SCA), providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest allows a patient's physician time to assess their long-term arrhythmic risk and make appropriate plans. The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. The LifeVest does not require bystander intervention and has a 98 percent first treatment shock success rate for resuscitating patients with SCA.
In the News
None at this time.